Verified Clinical Trials (VCT) and IntegReview IRB have developed an expedited research subject authorization review process. Research sites, CROs, and Sponsors will benefit from this alliance in an effort to stop dual enrollment and reduce significant protocol deviations in clinical trials.
By working together in a strategic partnership, VCT and IntegReview IRB have created and streamlined a simple process to improve research subject safety and improve data quality. Working together, both companies have developed a research subject Authorization Form to be utilized by research site staff, when employing Verified Clinical Trials’ services. VCT services allow the research site staff to check multiple inclusion or exclusion criteria such as concurrent enrollment, prior compound exposure, half-life violations or current screening at another site immediately following authorization form execution.
Click on the INTEGREVIEW IRB logo to access their website and learn more.